Trinity Financial Advisors LLC Takes $204,000 Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Trinity Financial Advisors LLC purchased a new stake in Axon Enterprise, Inc. (NASDAQ:AXON) during the fourth quarter, HoldingsChannel reports. The firm purchased 790 shares of the biotechnology company’s stock, valued at approximately $204,000.

A number of other large investors have also added to or reduced their stakes in AXON. AE Wealth Management LLC raised its stake in Axon Enterprise by 32.4% in the 3rd quarter. AE Wealth Management LLC now owns 1,775 shares of the biotechnology company’s stock valued at $353,000 after acquiring an additional 434 shares during the period. Asset Management One Co. Ltd. increased its position in Axon Enterprise by 7.5% during the 3rd quarter. Asset Management One Co. Ltd. now owns 29,085 shares of the biotechnology company’s stock worth $5,788,000 after buying an additional 2,030 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund increased its position in Axon Enterprise by 21.0% during the 3rd quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 17,300 shares of the biotechnology company’s stock worth $3,443,000 after buying an additional 3,000 shares during the period. Cambridge Investment Research Advisors Inc. increased its position in Axon Enterprise by 8.9% during the 3rd quarter. Cambridge Investment Research Advisors Inc. now owns 7,716 shares of the biotechnology company’s stock worth $1,535,000 after buying an additional 630 shares during the period. Finally, Xponance Inc. increased its position in Axon Enterprise by 1.1% during the 3rd quarter. Xponance Inc. now owns 16,518 shares of the biotechnology company’s stock worth $3,287,000 after buying an additional 186 shares during the period. Institutional investors own 79.08% of the company’s stock.

Analyst Ratings Changes

Several research firms have weighed in on AXON. The Goldman Sachs Group increased their price objective on Axon Enterprise from $297.00 to $339.00 and gave the stock a “buy” rating in a research report on Wednesday, February 28th. StockNews.com cut Axon Enterprise from a “buy” rating to a “hold” rating in a research report on Thursday, March 14th. TheStreet cut Axon Enterprise from a “b” rating to a “c+” rating in a research report on Tuesday, February 27th. Needham & Company LLC restated a “buy” rating and issued a $400.00 price target on shares of Axon Enterprise in a research report on Wednesday, April 24th. Finally, JPMorgan Chase & Co. raised their price target on Axon Enterprise from $330.00 to $365.00 and gave the stock an “overweight” rating in a research report on Thursday, April 11th. Two investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $323.09.

Axon Enterprise Trading Down 0.8 %

Shares of NASDAQ:AXON traded down $2.40 during midday trading on Wednesday, hitting $311.26. 519,743 shares of the stock were exchanged, compared to its average volume of 467,038. The stock has a market capitalization of $23.49 billion, a price-to-earnings ratio of 135.74 and a beta of 0.93. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.66 and a current ratio of 3.00. The business’s 50-day moving average price is $306.01 and its 200 day moving average price is $263.59. Axon Enterprise, Inc. has a 12 month low of $175.37 and a 12 month high of $329.87.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 EPS for the quarter, beating the consensus estimate of $0.48 by $0.29. Axon Enterprise had a return on equity of 14.11% and a net margin of 11.14%. The business had revenue of $432.14 million for the quarter, compared to analysts’ expectations of $418.97 million. Analysts predict that Axon Enterprise, Inc. will post 2.44 earnings per share for the current year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.